Edition:
United Kingdom

Surmodics Inc (SRDX.OQ)

SRDX.OQ on NASDAQ Stock Exchange Global Select Market

73.10USD
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
$73.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,782
52-wk High
$73.20
52-wk Low
$24.60

Chart for

About

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $417.55
Shares Outstanding(Mil.): 13.11
Dividend: --
Yield (%): --

Financials

  SRDX.OQ Industry Sector
P/E (TTM): 68.97 32.29 32.76
EPS (TTM): 0.46 -- --
ROI: 5.07 13.92 14.61
ROE: 5.82 16.77 16.33

BRIEF-Surmodics Acquires Thrombectomy Technology Assets

* SURMODICS ACQUIRES THROMBECTOMY TECHNOLOGY ASSETS FROM EMBOLITECH, STRENGTHENING PERIPHERAL VASCULAR WHOLE-PRODUCT SOLUTIONS PORTFOLIO

14 May 2018

BRIEF-Surmodics Reports Q2 Non-GAAP EPS $0.07

* SURMODICS REPORTS SECOND QUARTER FISCAL 2018 RESULTS, INCREASES FISCAL 2018 GUIDANCE

02 May 2018

BRIEF-Surmodics Announces FDA Clearance Of A New .018” Low-Profile Pta Balloon Dilation Catheter

* SURMODICS ANNOUNCES FDA CLEARANCE OF A NEW .018” LOW-PROFILE PTA BALLOON DILATION CATHETER

23 Apr 2018

BRIEF-Abbott And Surmodics Announce Agreement For Next-Generation Drug-Coated Balloon

* ABBOTT AND SURMODICS ANNOUNCE AGREEMENT FOR NEXT-GENERATION DRUG-COATED BALLOON

27 Feb 2018

Competitors

Earnings vs. Estimates